Evidence map›Paper›PMID 37730815›Full record

ArticleScientific reports2023

In vitro oxygen imaging of acellular and cell-loaded beta cell replacement devices.

Mrignayani Kotecha, Longhai Wang, Safa Hameed, Navin Viswakarma, Minglin Ma, Cherie Stabler, Corinne A Hoesli, Boris Epel

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Reconfigurable animal bed-EPR resonator assembly for multimodal co-registration.Journal of magnetic resonance (San Diego, Calif. : 1997) · 2026
    Article
  5. Computationally efficient 4D spectral-spatial EPR imaging.Journal of magnetic resonance (San Diego, Calif. : 1997) · 2025
    Article
  6. Accelerated EPR imaging using deep learning denoising.Magnetic resonance in medicine · 2025
    Article
  7. Article
  8. Article
  9. pOJournal of biomedical materials research. Part A · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Mrignayani KotechaOxygen Measurement Core, O2M Technologies, LLC, Chicago, IL, 60612, USA. mkotecha@oxygenimaging.com.ORCID http://orcid.org/0000-0003-2264-0247
Longhai WangDepartment of Biological and Environmental Engineering, Cornell University, NY, 14853, USA.
Safa HameedOxygen Measurement Core, O2M Technologies, LLC, Chicago, IL, 60612, USA.
Navin ViswakarmaOxygen Measurement Core, O2M Technologies, LLC, Chicago, IL, 60612, USA.
Minglin MaDepartment of Biological and Environmental Engineering, Cornell University, NY, 14853, USA.ORCID http://orcid.org/0000-0002-9553-7526
Cherie StablerDepartment of Biomedical Engineering, University of Florida, Gainesville, FL, 32611, USA.ORCID http://orcid.org/0000-0003-0573-0646
Corinne A HoesliDepartment of Chemical Engineering, McGill University, Montreal, QC, H3C 0C5, Canada.ORCID http://orcid.org/0000-0002-5629-7128
Boris EpelOxygen Measurement Core, O2M Technologies, LLC, Chicago, IL, 60612, USA.
Cornell University · USMcGill University · CASOS Oxygène (France) · FRUniversity of Chicago · USUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 1 diabetes (T1D) is an autoimmune disease that leads to the loss of insulin-producing beta cells. Bioartificial pancreas (BAP) or beta cell replacement strategies have shown promise in curing T1D and providing long-term insulin independence. Hypoxia (low oxygen concentration) that may occur in the BAP devices due to cell oxygen consumption at the early stages after implantation damages the cells, in addition to imposing limitations to device dimensions when translating promising results from rodents to humans. Finding ways to provide cells with sufficient oxygenation remains the major challenge in realizing BAP devices' full potential. Therefore, in vitro oxygen imaging assessment of BAP devices is crucial for predicting the devices' in vivo efficiency. Electron paramagnetic resonance oxygen imaging (EPROI, also known as electron MRI or eMRI) is a unique imaging technique that delivers absolute partial pressure of oxygen (pO

Indexed as

Diabetes Mellitus, Type 1InsulinsBiocompatible MaterialsHumansHypoxiaOxygenBiocompatible MaterialsInsulinsOxygen

Identifiers

PMID37730815
PMCPMC10511476
OpenAlexW4386887538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.